rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Lakefront Biotherapeutics - American Depositary Shares

LKFT · Nasdaq

Health CareBiotechnologyAbove a falling average

LKFT stood above a rising 150-day average in 18 of the last 52 weekly readings, and has been out of that trend for the last 33 weeks. It is 9.2% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 33
Industry in uptrend
18% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
75 (-9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.

23 Apr – 22 Oct
18%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders75-9 on the quarter
New · exited12 · 21
Reported value$959.1M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
GILEAD SCIENCES, INC.unchanged · filed 3 Aug 202616,707,477$500.2M00.0%
TANG CAPITAL MANAGEMENT LLCunchanged · filed 14 Aug 20263,785,991$113.5M00.0%
Madison Avenue Partners, LPadded · filed 14 Aug 20263,447,807$103.4M+982,628+39.9%
Prosight Management, LPadded · filed 14 Aug 20262,043,344$61.3M+493,344+31.8%
EcoR1 Capital, LLCunchanged · filed 14 Aug 20261,667,119$50.0M00.0%
AMERIPRISE FINANCIAL INCreduced · filed 14 Aug 20261,272,249$38.1M-152,425−10.7%
DME Capital Management, LPunchanged · filed 14 Aug 2026482,746$14.5M00.0%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026407,800$12.2M+92,400+29.3%
BlackRock, Inc.added · filed 7 Aug 2026338,152$10.1M+26,046+8.3%
Point72 Asset Management, L.P.reduced · filed 14 Aug 2026269,814$8.1M-62,311−18.8%
31 Mar 2023 – 30 Jun 2026
627587Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Nobody on record has traded it.

Same industry

MRNA ModernaLeading+118%
ENTX Entera BioLeading+51%
XNCR XencorLeading+44%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 31 Dec 20250.0%

Analyst forecasts

No analyst forecasts yet.